CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 46 filers reported holding CASI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $923,000 | +1.2% | 1,141,064 | 0.0% | 0.00% | – |
| Q4 2021 | $912,000 | -18.9% | 1,141,064 | +20.8% | 0.00% | – |
| Q3 2021 | $1,124,000 | +3.0% | 944,729 | +34.2% | 0.00% | – |
| Q2 2021 | $1,091,000 | -58.4% | 703,888 | -35.6% | 0.00% | – |
| Q1 2021 | $2,622,000 | -7.2% | 1,092,677 | +14.1% | 0.00% | – |
| Q4 2020 | $2,824,000 | +134.4% | 957,338 | +21.5% | 0.00% | – |
| Q3 2020 | $1,205,000 | -38.3% | 788,010 | +0.8% | 0.00% | – |
| Q2 2020 | $1,953,000 | +35.8% | 781,473 | +10.8% | 0.00% | – |
| Q1 2020 | $1,438,000 | -65.8% | 705,108 | -48.2% | 0.00% | – |
| Q4 2019 | $4,208,000 | +86.3% | 1,362,092 | +101.4% | 0.00% | -100.0% |
| Q3 2019 | $2,259,000 | +6.7% | 676,426 | +2.2% | 0.00% | 0.0% |
| Q2 2019 | $2,118,000 | +18.6% | 662,146 | +6.4% | 0.00% | – |
| Q1 2019 | $1,786,000 | -62.0% | 622,336 | -46.8% | 0.00% | -100.0% |
| Q4 2018 | $4,702,000 | +97.8% | 1,169,940 | +129.8% | 0.00% | 0.0% |
| Q3 2018 | $2,377,000 | -38.7% | 509,155 | +8.1% | 0.00% | 0.0% |
| Q2 2018 | $3,876,000 | +312.3% | 471,019 | +108.8% | 0.00% | – |
| Q1 2018 | $940,000 | +28.2% | 225,578 | 0.0% | 0.00% | – |
| Q4 2017 | $733,000 | +994.0% | 225,578 | +488.7% | 0.00% | – |
| Q3 2017 | $67,000 | +67.5% | 38,315 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | -25.9% | 38,315 | -1.0% | 0.00% | – |
| Q1 2017 | $54,000 | +22.7% | 38,700 | 0.0% | 0.00% | – |
| Q4 2016 | $44,000 | +4.8% | 38,700 | 0.0% | 0.00% | – |
| Q3 2016 | $42,000 | -6.7% | 38,700 | 0.0% | 0.00% | – |
| Q2 2016 | $45,000 | +9.8% | 38,700 | 0.0% | 0.00% | – |
| Q1 2016 | $41,000 | +10.8% | 38,700 | 0.0% | 0.00% | – |
| Q4 2015 | $37,000 | -9.8% | 38,700 | 0.0% | 0.00% | – |
| Q3 2015 | $41,000 | -40.6% | 38,700 | 0.0% | 0.00% | – |
| Q2 2015 | $69,000 | +23.2% | 38,700 | 0.0% | 0.00% | – |
| Q1 2015 | $56,000 | +9.8% | 38,700 | 0.0% | 0.00% | – |
| Q4 2014 | $51,000 | -26.1% | 38,700 | 0.0% | 0.00% | – |
| Q3 2014 | $69,000 | – | 38,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |